Corvus Pharmaceuticals (CRVS) Amortizatization of Intangibles (2016 - 2026)
Corvus Pharmaceuticals' Amortizatization of Intangibles history spans 12 years, with the latest figure at $17000.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles fell 94.16% to $17000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Mar 2026, down 16.39% year-over-year, with the annual reading at $1.3 million for FY2025, 17.88% up from the prior year.
- Amortizatization of Intangibles came in at $17000.0 for Q1 2026, down from $261000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $524000.0 in Q3 2024 to a low of -$83000.0 in Q3 2022.
- The 5-year median for Amortizatization of Intangibles is $242000.0 (2024), against an average of $209823.5.
- Year-over-year, Amortizatization of Intangibles crashed 318.42% in 2022 and then skyrocketed 545.0% in 2023.
- Corvus Pharmaceuticals' Amortizatization of Intangibles stood at $158000.0 in 2022, then fell by 19.62% to $127000.0 in 2023, then surged by 90.55% to $242000.0 in 2024, then rose by 7.85% to $261000.0 in 2025, then crashed by 93.49% to $17000.0 in 2026.
- Per Business Quant, the three most recent readings for CRVS's Amortizatization of Intangibles are $17000.0 (Q1 2026), $261000.0 (Q4 2025), and $459000.0 (Q3 2025).